Hyderabad: Pharma major Dr Reddy’s Laboratories Ltd completed the phase-3 trials of Russia’s COVID-19 vaccine – Sputnik V.
“We have completed the dosing for Phase-3,” a spokesperson of Dr Reddy’s Laboratories Ltd told BusinessLine. It was conducted with around 1,500 subjects and the results of the trial are expected to be out in early April.
The vaccine has been applied for emergency use in India but the government has sought phase-3 trial results. If approved, it will be the 3rd COVID-19 vaccine in India, after Covishield and Covaxin.
Dr. Reddy’s signed up with Russian Direct Investment Fund (RDIF) to conduct clinical trials of the vaccine and distribute it here, back in September 2020.
The vaccine has been developed by the Gamaleya National Research Institute of Epidemiology and Microbiology. It was the world’s first registered vaccine against COVID-19.
The company claims an efficacy of 91.6 per cent and has been authorised in 26 countries along with 2 million people.
Bargarh: Hrusikesh Bhoi, popular for his iconic role of Kansa in Bargarh’s Dhanu Jatra, has…
New Delhi: Canadian Prime Minister Justine Trudeau took to X to mark the sixth anniversary…
New Delhi: Israel on Thursday killed Hamas chief Yahya Sinwar in a Gaza operation. In…
New Delhi/Bhubaneswar: Three IAS officers, including Reghu G of Odisha cadre, have been shifted to…
Kolkata: A massive fire broke out at Sealdah ESI Hospital here on Friday morning. According…
New Delhi: The Enforcement Directorate Guwahati questioned actor Tamannaah Bhatia on Thursday in connection with…
Bhubaneswar: Days after the road rage incident involving an Army officer and his fiancee, a…
Mumbai: The Mumbai Traffic Police have received a threatening message via WhatsApp, demanding Rs 5…